(Q70824451)
Statements
A randomised comparison of monotherapy with Casodex 50 mg daily and castration in the treatment of metastatic prostate carcinoma. Casodex Study Group (English)
A V Kaisary
C J Tyrrell
C Beacock
G Lunglmayr
scientific article published on 01 January 1995